Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
17
NCT02697292
IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy
Phase: Phase 3
Role: Collaborator
Start: Feb 29, 2016
Completion: Dec 3, 2018